Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein

Background: Head and neck squamous cell carcinoma (HNSCC) is one most prevalent cancers among worldwide. Aim of this study was to evaluate possible effect of bevacizumab, a vascular endothelial growth (VEGF) factor monoclonal antibody on HNSCC cells in vitro to evaluate angiogenic profile changes. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Heydar, Hossein, Mansouri, Kamran, Norooznezhad, Maryam, Norooznezhad, Fatemeh, Mohamadnia, Abdolreza, Bahrami, Naghmeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141426/
https://www.ncbi.nlm.nih.gov/pubmed/30233776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141426/
https://www.ncbi.nlm.nih.gov/pubmed/30233776

Ejemplares similares